KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Notes Payables (2017 - 2025)

Novartis Ag's Notes Payables history spans 9 years, with the latest figure at $682.0 million for Q4 2025.

  • On a quarterly basis, Notes Payables rose 6.23% to $682.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $682.0 million, a 6.23% increase, with the full-year FY2025 number at $682.0 million, up 6.23% from a year prior.
  • Notes Payables hit $682.0 million in Q4 2025 for Novartis Ag, up from $642.0 million in the prior quarter.
  • Over the last five years, Notes Payables for NVS hit a ceiling of $899.0 million in Q4 2021 and a floor of $624.0 million in Q4 2023.
  • Historically, Notes Payables has averaged $742.0 million across 5 years, with a median of $682.0 million in 2025.
  • Biggest five-year swings in Notes Payables: fell 27.69% in 2023 and later rose 6.23% in 2025.
  • Tracing NVS's Notes Payables over 5 years: stood at $899.0 million in 2021, then dropped by 4.0% to $863.0 million in 2022, then dropped by 27.69% to $624.0 million in 2023, then grew by 2.88% to $642.0 million in 2024, then rose by 6.23% to $682.0 million in 2025.
  • Business Quant data shows Notes Payables for NVS at $682.0 million in Q4 2025, $642.0 million in Q4 2024, and $624.0 million in Q4 2023.